Chemkart India Limited (BOM:544442)

Market Cap	2.26B
Revenue (ttm)	2.03B
Net Income (ttm)	242.71M
Shares Out	9.50M
EPS (ttm)	25.55
PE Ratio	9.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,800
Average Volume	149,760
Open	241.05
Previous Close	243.70
Day's Range	240.40 - 244.95
52-Week Range	230.00 - 262.00
Beta	n/a
RSI	31.49
Earnings Date	n/a

About CTI BioPharma

Chemkart India Limited engages in trading of various food and health ingredients in India. It offers amino acids, health supplement, herbal extract, nucleotide, protein, sports nutrition, and vitamins. The company also provides nutritional supplements and components, such as glycine, creatine monohydrate 200mesh, inositol, L-arginine, L-glutamine, L-carmitne, N-acetyl L-cysteine, taurine, lglutathione, and whey protein concentate. It also engages in the trading and processing of nutraceutical products. The company exports in Germany, Nepal, New...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2020
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544442

Financial Performance

In 2024, Chemkart India's revenue was 2.03 billion, an increase of 53.97% compared to the previous year's 1.32 billion. Earnings were 242.71 million, an increase of 67.18%.